ISIS Pharmaceuticals (ISIS) Hit Following Two-Notch Analyst Downgrade
Tweet
Share
E-mailGet Alerts ISIS Hot Sheet
Join SI Premium – FREE
ISIS Pharmaceuticals (Nasdaq: ISIS) is getting hit Thursday, following a two-notch downgrade at Jefferies, issued earlier.
Shares are over 9 percent lower on the session with volume over 500K shares so far.
Shares are over 9 percent lower on the session with volume over 500K shares so far.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hunterbrook Capital is short bonds issued by Sammons Financial Group and short Guggenheim Strategic Opportunities Fund
- Jefferies: Used business jet inventories drop 45% year-over-year in August
- Jefferies Assumes L3Harris Technologies (LHX) at Hold
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
